Wednesday, 10/12/2014 17:29

DHG: Explanation for business result in Q3/2014

DHG Pharmaceutical Joint Stock Company has explained the decrease in profit of Quarter 3/2014 compared to Quarter 3/2013:

By: million dongs

 

09 months of 2014

09 months of 2013

Different

Quarter 3

09 months

Quarter 3

09 months

Quarter 3

09 months

Value

Ratio

Value

Ratio

Net revenue

872,553

2,440,312

736,945

2,117,709

135,608

18.40

322,604

15.23

Profit before tax

147,966

503,527

247,077

561,915

-99,111

-40.11

-58,387

-10.39

Profit after tax

117,087

412,451

190,029

447,711

-72,942

-38.38

-35,260

-7.88

 

Reason:

-  Revenue in Quarter 3/2014 increased 18.4%. In the first 09 months of 2014, revenue increased 15.23%.

-  In 2013, the firm made science and technology funds by 5% of profit after tax.

-  In Quarter 3/2013, net revenue from transferring Eugica trademark (VND122 billion), leading to profit in Quarter 3/2014 and in the first 09 months of 2014 were less than 2013.

 

HOSE

Other News

>   NNC: Explanation for business result in quarter 3/2014 (10/12/2014)

>   NVN: Explanation for business results in Quarter 3.2014 (10/12/2014)

>   ACBS: Resignation of Head of the branch (10/12/2014)

>   SHS: Change in Business Registration Certificate (10/12/2014)

>   SD5: Change in Business Registration Certificate (10/12/2014)

>   Saigon Ground Services sells shares at excellent price (10/12/2014)

>   HSG: Information on business license of branch in Yen Dinh – Thanh Hoa (10/12/2014)

>   KSA: Announcement of changes in business license (10/12/2014)

>   LCG: Announcement of changes in business license (10/12/2014)

>   DNSE: Change of Head Office Address (10/12/2014)

Online Services
iDragon
Place Order

Là giải pháp giao dịch chứng khoán với nhiều tính năng ưu việt và tinh xảo trên nền công nghệ kỹ thuật cao; giao diện thân thiện, dễ sử dụng trên các thiết bị có kết nối Internet...
User manual
Updated version